ZNTL - Zentalis Pharmaceuticals director purchases 17K company shares
2023-11-14 13:22:34 ET
More on Zentalis Pharmaceuticals
- Zentalis: Latest Market Sell-Off Looks Justified With Data Catalysts Long Way Off
- Zentalis: A Buy As Small Molecule Trials Continue To Advance
- Wedbush cuts Zentalis to neutral, cites strategy shift for ovarian cancer drug
- Zentalis hits 52-week low as Leerink downgrades on data for lead asset
- Seeking Alpha’s Quant Rating on Zentalis Pharmaceuticals
For further details see:
Zentalis Pharmaceuticals director purchases 17K company shares